Analysts expect MiNK Therapeutics, Inc. to report revenue of 1.65 M for Q3 26, against a range of 1.50 M to 1.79 M. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.79 M | 1.87 M | 0.00 | 0.00 | 1.57 M | 1.94 M | 672,844.18 | 341,587.22 | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 M | 1.54 M | 0.00 | 0.00 | 1.38 M | 1.78 M | 621,440.38 | 314,413.06 | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.65 M | 1.71 M | 0.00 | 0.00 | 1.47 M | 1.86 M | 647,142.28 | 328,000.14 |
Analysts expect MiNK Therapeutics, Inc. to report earnings per share of -0.34 for Q3 26, against a range of -0.36 to -0.32. The most recent reported quarter, Q2 26, came in at -0.62, a 10.7% miss against the -0.56 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.50 | -0.62 | -0.70 | -1.06 | -0.65 | -0.52 | -0.57 | -0.62 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.73 | -0.47 | -0.57 | -0.47 | -0.87 | -0.64 | -0.68 | -0.53 | -0.32 | -0.37 | -1.12 | -1.04 | -0.47 | -0.38 | -0.78 | -0.81 | ||||||||||
| Low Estimate | -0.81 | -0.53 | -0.67 | -0.55 | -0.95 | -0.78 | -0.76 | -0.59 | -0.36 | -0.45 | -1.22 | -1.14 | -0.57 | -0.46 | -0.92 | -0.93 | ||||||||||
| Consensus Estimate | -0.77 | -0.50 | -0.62 | -0.51 | -0.91 | -0.71 | -0.72 | -0.56 | -0.34 | -0.41 | -1.17 | -1.09 | -0.52 | -0.42 | -0.85 | -0.87 |
Pull Wall Street consensus for MiNK Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=INKT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "INKT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=INKT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();